Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 8;23(1):14.
doi: 10.1186/s12969-025-01064-9.

Lack of HLH in FMF

Ozge Basaran #  1 , Erdal Sag #  1   2 , Elif Arslanoglu Aydın  3 , Busra Aydın  2 , Nur Kübra Tasdemir  2 , Elif Celikel  4 , Yagmur Bayındır  1 , Semanur Özdel  3 , Yelda Bilginer  1 , Alexei A Grom #  5 , Seza Ozen #  6   7
Affiliations

Lack of HLH in FMF

Ozge Basaran et al. Pediatr Rheumatol Online J. .

Abstract

Background: Macrophage activation syndrome (MAS) is a severe complication of systemic juvenile idiopathic arthritis (sJIA), driven by excessive activation of T cells and macrophages, resulting in a cytokine storm. IFN-γ and IL-18 play crucial roles, with monocyte and macrophage hyperresponsiveness to IFN-γ amplifying MAS-related inflammation. Familial Mediterranean Fever (FMF), an autosomal recessive disease, is characterized by recurrent fever episodes due to MEFV gene mutations. Despite intense inflammation in FMF, MAS is rare. This study aimed to compare in vitro responsiveness of peripheral blood mononuclear cells (PBMCs) to IFN-γ between sJIA/MAS and FMF patients.

Methods: Five sJIA/MAS and five FMF patients were included. PBMCs were stimulated in vitro with IFN-γ for 45 min. Levels of IFN-γ-induced chemokines CXCL9, CXCL10, and IL-18 in supernatants were measured using cytometric bead arrays before and after stimulation.

Results: PBMCs from MAS patients produced higher baseline CXCL9 levels compared to FMF patients in a flare, with differences increasing post-IFN-γ stimulation. IFN-γ stimulation also upregulated IL-18 production in MAS patients but not in FMF patients.

Conclusion: Enhanced responsiveness to IFN-γ distinguishes sJIA/MAS from FMF patients, which may explain the lower occurrence of MAS in FMF.

Keywords: CXCL-10; CXCL-9; Familial Mediterranean fever; IL-18; Macrophage activation syndrome.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: The study was approved by the local ethical committee of our university (GO20/1154) and all patients/parents provided informed consent. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
CXCL10 and 9 responses of the PBMCs from FMF and MAS patients and healthy controls (HC), after stimulation with IFNγ both in attack and remission periods
Fig. 2
Fig. 2
IL-18 levels of the culture supernatants from PBMCs of FMF and MAS patients and healthy controls (HC), after stimulation with IFNγ both in attack and remission periods
See this image and copyright information in PMC

References

    1. Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies. Annu Rev Med. 2015;66:145–59. 10.1146/annurev-med-061813-012806. - PMC - PubMed
    1. Ozen S. Update in familial Mediterranean fever. Curr Opin Rheumatol. 2021;33(5):398–402. 10.1097/BOR.0000000000000821. - PubMed
    1. Ramanan AV, Grom AA. Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? Rheumatology (Oxford). 2005;44(11):1350–3. 10.1093/rheumatology/keh710. - PubMed
    1. Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. 2015;34(8):1333–9. 10.1007/s10067-015-2923-0. - PubMed
    1. Bracaglia C, de Graaf K, Pires Marafon D, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166–72. 10.1136/annrheumdis-2015-209020. - PubMed

MeSH terms